本文对60例宫颈癌患者进行顺铂放射增敏的临床随机研究。增敏组用常规根治性放疗加顺铂治疗,对照组单行根治性放疗。结果表明:顺铂增敏组患者的宫颈局部肿瘤缩小和消失时间较对照组明显缩短,放射增敏比为1.846。增敏组用顺铂未出现严重毒性反应,患者对治疗的耐受性好。 This article presents a clinical randomized study of cisplatin radiation sensitization in 60 patients with cervical cancer. The sensitization group was treated with conventional radical radiotherapy plus cisplatin, and the control group was treated with single radical radiotherapy. The results showed that the shrinkage and disappearance time of cervical tumors in the cisplatin sensitization group was significantly shorter than that of the control group, and the radiosensitivity ratio was 1.846. The sensitization group did not experience severe toxicity with cisplatin, and patients were well tolerated for treatment.